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Apoptosis and activation of macrophages play an important role in the host response to mycobacterial infection involving
TNF-a as a critical autocrine mediator. The underlying mechanisms are still ill-defined. Here, we demonstrate elevated levels of
methylglyoxal (MG), a small and reactive molecule that is usually a physiological product of various metabolic pathways, and
advanced glycation end products (AGE) during mycobacterial infection of macrophages, leading to apoptosis and activation of
macrophages. Moreover, we demonstrate abundant AGE in pulmonary lesions of tuberculosis (TB) patients. Global gene
expression profiling of MG-treated macrophages revealed a diverse spectrum of functions induced by MG, including apoptosis
and immune response. Our results not only provide first evidence for the involvement of MG and AGE in TB, but also form
a basis for novel intervention strategies against infectious diseases in which MG and AGE play critical roles.
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INTRODUCTION
Tuberculosis (TB) represents a major threat to humankind,
causing approximately 2 million deaths each year. In the majority
of individuals infected with Mycobacterium tuberculosis (MTB), the
bacilli cause long-term asymptomatic infection termed latent TB
during which bacilli persist within granulomas in a dormant stage.
Latently infected individuals have a ca. 10% risk of progression to
clinical disease during their lifetime [1,2].
Within granulomas, macrophages undergo apoptosis, which
participates in host defence against TB [3,4]. Correlation between
apoptosis and virulence/persistence of mycobacteria remains
controversial. Virulent MTB have been described to induce more
profound apoptosis in macrophages and dendritic cells in vitro
than attenuated Mycobacterium bovis BCG (BCG) [5]. Yet, evidence
has also been presented that MTB attenuates host cell apoptosis in
infected macrophages via induction of antiapoptotic mechanisms
and/or upregulation of antiapoptotic genes [6–8]. Thus, although
the exact impact of MTB on apoptosis remains unclear, a role
of apoptosis in protection against, and pathogenesis of, TB is
likely.
Apoptosis can be induced by various physical and chemical
insults. Recent studies revealed that methylglyoxal (MG) induces
apoptosis in a cell-type-dependent manner [9–11]. The cytotox-
icity of MG involves apoptotic events. MG induces apoptosis in
Jurkat cells by activating the c-Jun N terminal kinase (JNK) signal
transduction pathway, which decreases the mitochondrial mem-
brane potential, followed by caspase-3 activation [11]. In cultured
HUVEC cells, MG induces tyrosine phosphorylation and
aggregation of a number of cellular proteins [12]. In aortic
VSMC from hypertensive rats, elevated levels of MG and
advanced glycation end products (AGE) are found, in parallel
with evidence that MG increases oxidative stress, activates NF-kB,
and enhances ICAM-1 expression [13]. MG can modify proteins
rapidly and cause cross-linking, probably changing the properties
of these proteins and thus triggering intracellular responses.
Abordo and Thornalley demonstrated that MG-modified human
serum albumin (MG-HSA) induces increased expression of TNF-
a in human monocytic THP-1 cells [14]. Together, these studies
suggest that MG-modified proteins play an intriguing role in the
development of distinct disease states.
Results of global gene expression analysis of MTB isolated from
active pulmonary TB indicate that the tissue environment of MTB
in vivo, particularly in granulomatous lesions, is rich in MG [15].
Since a significant number of macrophages in these lesions
undergo apoptosis [3], we hypothesized that MG levels in
macrophages determine apoptotic events during mycobacterial
infection. To contest this hypothesis, we measured MG levels in
macrophages during mycobacterial infection, characterized MG-
induced apoptosis, and ascertained the relationship between
elevated levels of MG/AGE and macrophage functions during
mycobacterial infection. Our findings point to a close interrelation
between MG/AGE and apoptosis as well as activation of
macrophages during TB.
RESULTS AND DISCUSSION
Mycobacterial Infection of Macrophages Triggers
Increased MG Production
Our DNA array results suggest that the environment of tubercle
bacilli at sites of infection is rich in aldehydes, especially MG [15].
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To verify the assumption of an MG-rich environment during
mycobacterial infection of the lung, we infected MH-S cells ex vivo
with mycobacteria and measured relative MG levels in these cells.
MH-S cells are an established murine alveolar macrophage-
derived cell line. Alveolar macrophages play a pivotal role at the
initial innate immune response against infection of tubercle bacilli
via the respiratory tract [1]. Moreover, recent evidence reveals
that alveolar macrophages are able to mount appropriate immune
response [16]. We observed that MG levels significantly increased
in MH-S cells 1 day after mycobacterial infection as determined
by HPLC (Figures S1A–C). In three independent experiments,
MG levels were 2.0–3.7 times higher in mycobacteria-infected
macrophages as compared to noninfected macrophages. This level
of augmentation is comparable to that in in vitro-induced
hyperglycemia and in the blood of diabetic patients [17,18].
These findings demonstrate for the first time that MG levels are
significantly increased during mycobacterial infection of macro-
phages. In general, MG is a physiological product of various
metabolic pathways, including anaerobic glycolysis, oxidative
decomposition of polyunsaturated fatty acids as well as fragmen-
tation of triosephosphate or catabolism of ketone bodies and
threonine. MG, 3-deoxyglucosone (3-DG), and glyoxal (GO) are
formed during each step of the glycation process by degradation of
glucose or Schiff’s base in early glycation, or from Amadori
products such as fructosamine in the intermediate stages of
glycation [19,20]. MG levels in cells are regulated by several
factors including the glyoxalase system and other components
which influence the glycolysis pathway. The glyoxalase enzyme
system in eukaryotic cells, which comprises glyoxalase I and II, is
primarily responsible for detoxification of MG [21–23]. Increased
levels of glucose or deprivation of phosphate in the cytoplasm can
induce MG production by interfering with the glycolysis pathway
[24]. It is thus possible that mycobacterial infection of macro-
phages triggers shifts in these metabolic pathways leading to
increased MG production. We cannot formally exclude that
mycobacteria directly contribute to increased MG levels of
infected macrophages. For instance, reactive oxygen radicals
produced during mycobacterial infection may oxidize polyunsat-
urated fatty acids, which represent abundant components of the
mycobacterial cell wall, leading to their decomposition and MG
formation. Moreover, our microarray data from pulmonary TB
patients indicate that MTB experiences nutrient deprivation at
sites of pulmonary TB [15]. Such conditions may alter MTB
metabolic pathways leading to MG formation. Due to its highly
reactive and small molecular nature, MG can easily diffuse out of
mycobacterial cells into host cells.
MG Induces Apoptosis in MH-S Cells
In an attempt to unravel the function of MG during mycobacterial
infection, we assessed whether MG plays a role in apoptosis of
infected MH-S cells. Basically two observations support this
notion. First, MG induces apoptosis in different cell lines [11];
second, granuloma formation is accompanied by apoptosis of
macrophages [3]. Consistent with this, a high proportion of
apoptotic cells was found in bronchoalveolar lavage from patients
with reactive or disseminated TB [25]. In vitro models have
demonstrated that mycobacteria cause apoptosis and apoptosis of
host macrophages has been claimed to restrict growth of
intracellular mycobacteria [6].
Accordingly, we first investigated the ability of MG to induce
apoptosis in MH-S cells. Apoptosis occurred in this cell line, as
assessed by staining of chromosomal DNA with propidium iodide
(PI) followed by cellular analysis using the FACScalibur flow
cytometer (Figures 1A and S2). The percentage of apoptotic cells
peaked at an MG concentration of 0.8 mM. At an MG
concentration of 1.6 mM the proportion of apoptotic cells
decreased. A possible explanation for this observation is that
MG induces profound necrosis rather than apoptosis in MH-S
cells at this high concentration, as observed recently in Jurkat cells
[11]. Alternatively, at this high concentration MG triggers growth
arrest at the G1 phase in MH-S cells as reported previously for
other cell types [10]. We observed increased externalization of
phosphatidylserine, as an early sign of apoptosis 4 h after MG
treatment (Figure S3) indicating that apoptotic signals were
induced prior to this time point.
JNK plays an important role in apoptotic processes [26–28].
The induction of apoptosis by MG has been correlated with the
activation of c-Jun N-terminal kinase (JNK) [11]. To examine the
apoptotic route of MG-treated MH-S cells, total proteins of MG-
treated MH-S cells were isolated at different time points after
treatment and JNK, caspase-3, and caspase-9 activation were
determined. JNK was activated as early as 1 h after MG treatment
Figure 1. MG Induces Apoptosis in the Murine Alveolar Macrophage
Cell Line MH-S (A) MH-S cells were treated with different concentrations
of MG for 24 h. Cells were stained with propidium iodide and analyzed
using a FACS instrument. Apoptosis was scored as the percentage of
cells appearing in the area below the G1/G0 peak, representing cells
containing DNA,2N. Error bars represent6SD. Statistical significance
was determined by Student’s t test; *, P,0.001 for MH-S cells treated
with 0.4, 0.8, and 1.6 mM MG versus untreated MH-S cells. (B) Western
blot analysis was used to detect the activation of components of
apoptotic signals, JNK, caspase-3, and caspase-9. JNK was activated as
early as 1 h after MG treatment, followed by the activation of caspase-3
and caspase-9.
doi:10.1371/journal.pone.0000029.g001
Methylglyoxal in MTB Infection
PLoS ONE | www.plosone.org 2 December 2006 | Issue 1 | e29
and this activation was maintained for 2 h. Caspase-3 and caspase-
9 activation occurred 4 h after MG treatment (Figure 1B).
The activation of JNK can occur upstream or downstream of
caspase activation. When JNK activation precedes caspase
activation, it is usually required for apoptosis. This is particularly
relevant when cells are exposed to insults caused by various
chemical agents, irradiation, or oxidation [29,30]. Our results
suggest that activation of JNK precedes the onset of apoptosis, and
initiates an intracellular signaling cascade in preparation for
apoptosis induced by MG in MH-S cells. We conclude that JNK
activation is required for MG-induced apoptosis of MH-S cells.
Our results agree with previous reports [11], extending the
apoptosis-inducing potential of this small molecule to alveolar
macrophages.
Increased AGE Levels in Mycobacteria-infected
Macrophages
Under physiological conditions, most MG is bound to cellular
proteins as adducts formed with Lys, Arg, and Cys residues.
Although the reaction with Cys is considered reversible, elevated
MG concentrations can irreversibly modify Lys and Arg residues
through AGE formation. AGE can enhance formation of oxygen
radicals with subsequent activation of NF-kB and release of
proinflammatory cytokines [31,32]. AGE can stimulate mitogen-
activating protein kinase (MAPK), activator protein-1 (AP-1), and
induce expression of transforming growth b1 (TGF-b1) and of
extracellular matrix (ECM) proteins [33,34]. It is, therefore,
conceivable that abundant MG levels present during mycobacte-
rial infection of macrophages lead to AGE formation of distinct
proteins, which then trigger changes in global gene expression. In
hyperglycemia, increased levels of MG are accompanied by
elevated AGE formation [17]. We observed abundant AGE
during mycobacterial infection of macrophages (Figure 2A). More
importantly, we detected AGE in TB lesions of patients. Figure 2B
shows a histological specimen of lung lesion from a TB patient.
AGE staining colocalizes with the accumulation of macrophages
suggesting that macrophages are one of the main sources of AGE
in active TB. Thus, formation and accumulation of AGE occurs in
TB. Until recently, increased AGE formation has been mostly
associated with diabetes, renal failure, aging, and cancer [35].
Therefore, our observation extends the roles of AGE to chronic
infectious diseases such as TB and hence, provides new insights
into regional immunity against, and pathogenesis of, a chronic
bacterial infection.
Mycobacteria-induced Apoptosis Requires MG and
AGE
Reduced glutathione (GSH) serves as a cofactor of the glyoxalase
system and catalyzes the conversion of MG to D-lactate. MG
binds nonenzymatically to GSH forming hemithioacetal, which in
turn serves as a substrate for glyoxalase I (GLO1). Glyoxalase II
(GLO2) hydrolyzes the product from the GLO1-catalyzed
reaction, S-D-lactoylglutathione to D-lactate. GSH is also a well-
known antioxidant, which neutralizes oxidative radicals, including
oxygen radicals. Under various experimental conditions, induction
of apoptosis is preceded by a rise in intracellular oxygen radicals
[9]. MG can induce generation of reactive oxygen radicals
through multiple pathways [36–38] and these radicals contribute
to apoptotic events induced by MG [39]. We show that
preincubation of macrophages with GSH reduced AGE formation
after infection with mycobacteria (Figure 3A). At the same time we
observed a significant reduction in apoptosis (Figure 3B). Similar
results were obtained for MG-treated macrophages, which had
been preincubated with GSH (Figure 3C). This finding suggests
that mycobacteria-induced apoptosis of macrophages involves
elevated AGE levels.
MG Modulates Expression of Apoptosis- and
Immune Response-related Genes
In an effort to unravel the mechanism(s) of apoptosis induced by
MG, we performed global gene expression profiling of MG-treated
macrophages. Promptly after MG treatments (30 min), a cluster of
genes involved in apoptosis were induced (Tables S1–6) and many
of these were increasingly expressed at later time points. TNF-
a was induced at all time points analyzed confirming previous
reports that MG and AGE can induce TNF-a production [14].
Increased transcription of TNF-a was accompanied by a high level
of TNF-a protein in supernatants of macrophages treated with
MG (Figure 4A). In addition, several genes associated with TNF-a,
such as TRAF1, TRAF2, and members of the TNF-a receptor
superfamily were also induced (Tables S1–6). The expression of
some DNA damage-inducible genes, such as DDIT3 and
GADD45G was strongly elevated, indicating that MG directly
or/and indirectly causes DNA damage as a characteristic feature
of apoptosis (Tables S1–6).
Notably, MG does not only induce apoptosis-related genes, but
also a large number of genes related to macrophage activation and
induction of immunity. Beside TNF-a, a series of genes belonging
to the chemokine and cytokine families (ligands and receptors)
were induced (Tables S1–6). Among highly induced chemokines
were CXCL2 and CXCL10, which are highly abundant in lung
granulomas induced by mycobacteria [40]. The high expression of
Figure 2. Mycobacterial Infection of Macrophages Stimulates AGE
Formation. (A) Macrophages were infected with BCG for 1 day and AGE
levels were determined by FACS analysis. AGE formation was strongly
increased during infection of macrophages. (B) Significant formation of
AGE was also observed at sites of active TB; upper left: staining with
mAb against macrophage marker (CD68), upper right: staining with
mAb against AGE, lower right: staining with mAb against marker for
activated macrophages (Ki-67). Consistent results were observed for
three TB patients.
doi:10.1371/journal.pone.0000029.g002
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CXL10 was confirmed by real-time RT-PCR (Table S7) and
ELISA (Figure 4B). Furthermore, real-time RT-PCR results
showed that pretreatment of macrophages with GSH reduced
the induction of the corresponding genes (Table S7). This directly
indicates the involvement of MG in induction of these genes.
Lung granulomas represent the hallmark of pulmonary TB and
the prime focus for the continuous crosstalk between MTB and
immune cells [41]. Induction of immunity involves elaborate
interactions between chemokines and cytokines produced by
immune cells as well as local tissue cells [40,41]. TNF is a pivotal
player in granuloma formation [42,43]. TNF-deficient mice
infected with MTB are highly susceptible to disease, and
granuloma formation is severely impaired [42]. Therapeutic
TNF neutralization in rheumatoid arthritis patients with latent
MTB infection is associated with increased risk of reactivation TB
[44]. Thus, considering the large number of genes related to
chemokines and cytokines, the expression of which is strongly
regulated by MG, we suggest that MG and AGE play pivotal roles
in immunity to TB with a focus on the granulomatous lesion. This
assumption is supported by the fact that.70% of the genes, which
were regulated by MG (this study), are similarly regulated in
Figure 3. GSH Reverses Apoptotic Effects of MG/AGE on Macrophages.
(A) Macrophages were pretreated with GSH and infected with
mycobacteria for 1 day. As a positive control, macrophages were
infected with mycobacteria without pretreatment with GSH. AGE levels
were determined using a FACS instrument. Red line: negative control
(without infection), black line: positive control, blue line: pretreatment
with GSH. The augmentation of AGE levels was reduced during
mycobacterial infection when macrophages were pretreated with GSH.
(B) Pretreatment of macrophages with GSH reduced the proportion of
apoptotic cells during mycobacterial infection. Error bars represent6SD.
Statistical significance was determined by Student’s t test; *, P,0.05 for
MH-S cells pretreated with GSH and infected with mycobacteria versus
MH-S cells infected with mycobacteria without pre-treatment with GSH.
(C) Pretreatment of macrophages with GSH reduced the proportion of
apoptotic cells during MG treatment. Error bars represent6SD.
Statistical significance was determined by Student’s t test; **,
P,0.001 for MH-S cells pretreated with GSH and treated with MG
versus MH-S cells treated with MG without pretreatment with GSH.
doi:10.1371/journal.pone.0000029.g003
Figure 4. Cytokine and Chemokine Induction by MG. MH-S cells were
treated with 0.8 mM MG. TNF-a and CXCL10 concentrations in the
culture medium were measured at various time points as indicated on
the X axis. Relative OD values were calculated by setting the OD value
to 1 at time 0 h. A significant increase of TNF-a (A) and CXCL10
secretion (B) was observed after MG treatment of MH-S cells. This
confirms the results of microarray experiments. Error bars repre-
sent6SD. Statistical significance was determined by Student’s t test; *,
P,0.05 for MH-S cells treated with MG (6, 8, and 24 h after treatment
for TNF-a and 24 h after treatment for CXCL10) versus untreated MH-S
cells.
doi:10.1371/journal.pone.0000029.g004
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granulomas of MTB-infected mice (Tracy Walker, personal
communication).
Our global gene expression profiling of MG-treated macro-
phages revealed that MG effects the expression of numerous genes,
many related to apoptosis, activation, and immunity. Moreover,
MG seems to effect genes associated with regulation of cellular
growth. The glyoxalase system and MG have been proposed as
major regulators of cell division based on their ubiquitous
occurrence and the high reactivity of MG with cellular thiols
underlying cell division [45,46]. In sum, our experiments
revealed numerous roles of the small molecule MG in diverse
cellular events. Understanding the mechanism(s) involved in these
events can provide the basis for designing novel intervention
strategies against infectious diseases in which MG and AGE are
critical.
MATERIALS AND METHODS
In vitro Culture of Bacteria and Culture Conditions
BCG Copenhagen organisms were grown in Middlebrook 7H9
media supplemented with 10% (v/v) ADC (Difco Laboratories)
and 0.05% (v/v) Tween 80 (Sigma) to mid-log phase at 37uC with
shaking at 90 rpm in screw-capped bottles.
Culture of MH-S Cells
MH-S cells (ATCC No. CRL-2019) were cultured in RPMI
medium supplemented with 10% FCS, 1 mM Na-pyruvate, and
2 mM L-glutamate, 10 mM HEPES, 0.05 mM 2-mercaptoetha-
nol, 100 U/ml penicillin, and 10 mg/ml streptomycin sulphate.
The cells were maintained in a humidified atmosphere of 5% CO2
at 37uC. During mycobacterial infection, culture medium without
antibiotics was used. Infection of MH-S cells with BCG
Copenhagen was performed as described previously [6,7].
Flow Cytometric Analysis of DNA Fragmentation
MH-S cells were seeded at 2.56105 cells/ml into a 24-well tissue
culture plate for 1 day (2.56105 cells/well). After treatment with
0.8 mM MG (Sigma) for 24 h, cells were harvested, resuspended
in 500 ml of propidium iodide buffer (0.1% Triton X-100, 16PBS)
containing 50 mg/ml propidium iodide (Sigma), and incubated for
15 min on ice. DNA fragmentation analysis was carried out using
a FACScalibur flow cytometer (Becton Dickinson). Apoptosis was
scored by the percentage of cells appearing in the area below the
G1/G0 peak representing cells containing DNA,2N.
Annexin V Binding
One million MH-S cells were seeded into a 6-well plate for 1 day
and then treated with 0.8 mM MG, and harvested after MG
treatment for 4, 6, and 24 h. The MH-S cells were harvested,
washed twice with 16PBS, resuspended in annexin V binding
buffer, and stained with annexin V according to the manufac-
turer’s instructions (Sigma) before flow cytometric analysis.
Determination of MG Levels in MH-S Cells
Measurement of MG levels was performed as described previously
[23] with a few modifications. MH-S cells (26107) were infected
with BCG at MOI of 50:1. One day after infection, MH-S cells
were harvested, washed twice with 16PBS, and lysed by
sonication in 5 ml 16PBS. Perchloric acid (PCA) (Sigma) and o-
phenylenediamine (o-PD; Sigma) were added to a final concen-
tration of 0.5 M and 5 mM, respectively. The mixture was
incubated at 20uC for 24 h. PCA precipitate was removed by
centrifugation. The supernatant was passed through a C18 solid-
phase extraction cartridge (Waters Sep-Pak tC18 plus cartridge,
Millipore), which had been prepared by flushing with 6–8 ml of
acetonitrile and 6–8 ml of 10 mM KH2PO4 (pH 2.5). The sample
was eluted from the cartridge with 4 ml acetonitrile (Sigma). The
2-methylquinoxaline (2-MQ) content was analyzed by HPLC. 2-
MQ was eluted at a retention time of 7.1–7.3 min. Increase in MG
was determined by calculating the ratio of peak areas between
MH-S cells with and without infection. The obtained ratio was
normalized with the ratio of the corresponding cell numbers.
Cell Lysis and Immunoblot Analysis
Cells were lysed in lysis buffer containing 0.5% Nonidet P-40 (NP-
40), 20 mM Tris-HCl (pH 7.6), 0.15 mM NaCl, 3 mM EDTA,
3 mM EGTA, 1 mM DTT, 2 mM sodium vanadate, and
16proteinase inhibitor cocktail (Sigma). Lysates were cleared by
centrifugation at 13,000g for 10 min, denatured by boiling in
Laemmli buffer for 5 min, separated on 12.5% SDS-PAGE gels,
and blotted onto nitrocellulose membrane. Nonspecific binding
was blocked by incubating the membrane with 0.1% Tween-20/
PBS containing 5% nonfat dry milk for 1 h at room temperature.
Membranes were incubated in the blocking buffer with the
primary antibody: caspase-3 (Cell Signaling Technology), caspase-
9 (Cell Signaling Technology), or P-JNK (Sigma) overnight at 4uC,
followed by incubation with horseradish peroxidases (HRP)-
conjugated secondary antibody, and the specific immune com-
plexes were detected using the Western blot enhanced chemilu-
minescence (ECL)-based reagent (Amersham Biosciences).
Detection of AGE in Mycobacteria-infected
Macrophages
Monoclonal antibody (mAb) against AGE (RDI, ADYGLYabm,
clone 6D12) was labeled with Cy3 or Cy5 using Cy3/Cy5 Ab
Labeling Kit (Amersham Biosciences) according to the manufac-
turer’s protocol. Infected macrophages were harvested, fixed with
4% paraformaldehyde, and permeabilized in 16PBS containing
0.1% Triton X-100. The fixed macrophages were stained with the
labeled antibody and subjected to FACS analysis.
Immunohistological Staining
Due to extensive lung disease and prevalence of MDR isolates, TB
patients in Russia frequently undergo elective thoracic surgery.
Destructed parts of their lungs are removed within the anatomical
borders of lung segments to decrease mycobacterial load. Lung
tissue was obtained at the Department of Thoracic Surgery of the
Central Tuberculosis Research Institute (CTRI). At the time point
of elective surgical intervention, all TB patients were under
multidrug combination therapy of at least 3–4 first- and/or
second-line drugs. Immediately after surgery, removed lung tissue
was fixed in 4% paraformaldehyde. All procedures involving
patients were reviewed and approved by the appropriate ethical
review boards in both Moscow and Berlin. Informed consent was
obtained from each patient in this study.
The immunohistological staining of cell surface markers was
performed according to published protocols [47]. In brief, after
deparaffination, tissue sections were washed with H2O, incubated
in 1mM EDTA buffer at 2 bars for 3 min and then washed with
0.01% Tween 20 in PBS (TBS). Sections were incubated with
mAb against AGE (1:300, RDI, ADYGLYabm, clone 6D12),
CD68 (1:100; Biocarta, CM033B), pAbBCG (1:1000; DAKO,
Hamburg, Germany, B0124), or Ki-67 (1:75; DAKO, M7240),
respectively, for 1 h at room temperature. After washing in TBS,
sections were incubated with goat-anti-mouse/goat-anti-rabbit
polyclonal antibody labeled with alkaline phosphatase (AP;
Methylglyoxal in MTB Infection
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Dianova, Hamburg, Germany, 115-055-146 or 111-055-045) for
1 h. Bound antibodies were detected by color reaction using
naphthol AS-bi-phosphate solution containing neo-fuchsin and
sodium-nitrite (Merck, Darmstadt, Germany, 1.06549). Endoge-
nous alkaline phosphatase activity was blocked by levamisole
(Sigma, Taufkirchen, Germany, L9756). Counter staining was
performed with hem-alaun (Merck).
Measurement of TNF-a and CXCL10 Secretion
MH-S cells (26106) were treated with 0.8 mMMG in 4 ml culture
medium. The growth medium was removed at different time
points after MG treatment and assessed for TNF-a and CXCL10
content using Mouse TNF-alpha and CXCL10 DuoSet ELISA
Development Systems, respectively, (R&D Systems) according to
manufacturer’s instructions. The samples from each time point
were measured in triplicate. The error bars represent standard
deviation from three measurements. Relative OD values were
calculated by dividing each OD value with that of untreated
sample (0 h).
Gene Expression Profiling
After treatment with MG for 0, 0.5, 4.0, and 8.0 h, MH-S cells
were harvested, pelleted, resuspended in Trizol (Invitrogen), and
vortexed for 1 min to lyse the cells. Total RNA was extracted with
chloroform and precipitated in isopropanol. The RNA pellet was
washed twice with cold 70% ethanol.
The GeneChipH Mouse Genome 430 2.0 oligonucleotide
microarray (Affymetrix, Santa Clara, CA, USA) comprises
45,101 probe sets, which analyze the expression level of over
39,000 transcripts and variants from over 34,000 well-character-
ized mouse genes. Labeling of RNA targets, hybridization, and
post-hybridization procedures were performed according to
protocols provided by Affymetrix. Following washing and staining,
arrays were scanned twice at 1.56 mm resolution using a Gene-
ChipH Scanner 3000 (Affymetrix, Santa Clara, CA), controlled by
GCOS 1.3 software (Affymetrix). Photoemission was detected by
a photomultiplier tube through a 570-nm longpass filter.
Computer-generated array images were overlaid with a virtual
grid, controlled by GCOS 1.3 software. This step allowed
definition of each feature and alignment within known array
dimensions. About 40 pixels within each feature were averaged
after discarding outliers and pixels close to feature boundaries.
Gene expression levels were calculated according to the average
hybridization intensities of perfectly matched versus mismatched
oligonucleotide probes. Arrays were scaled by GCOS 1.3 software
to an average hybridization intensity of 2,500 per gene and
analyzed independently. After hybridization and image analysis
we excluded probe sets with absent calls in all 12 samples or with
nonsignificant hybridization intensities.
The Data Mining Tool 3.1 (Affymetrix) and GeneSpring
software package 7.2 (Silicon Genetics, Redwood City, CA) were
used to compare the untreated control sample (0 h time point)
with MG-treated samples at different time points. The data were
normalized to compensate for variability in hybridizations and
hybridization artefacts. The normalization consisted of three
sections:
1. Data transformation: set measurements,300 to 300.
2. Normalize each chip to 50th percentile of the measurements
taken from that chip.
3. Normalize each gene to the median of the measurements for
that gene.
The GeneSpring software package 7.2 was used to identify
coexpressed genes within a set of gene expression data typically
obtained using the microarray technology. The coexpression
information was in turn used to help identify the biological
function of the genes. To identify potential biological functions
associated with gene clusters, we analyzed the Gene Ontology
(GO) annotations of coexpressed genes.
Microarray data are deposited in GEO (http://www.ncbi.nih.
gov/geo/; accession number: GSE3837).
Quantitative Real-time RT-PCR of MH-S cells
MH-S cells were treated with 0.8 mMMG for 4 h with or without
pretreatment with GSH. After treatment, MH-S cells were
harvested, pelleted, resuspended in Trizol (Invitrogen), and
vortexed for 1 min to lyse the cells. Total RNA was extracted
with chloroform and precipitated in isopropanol. The RNA pellet
was washed once with cold 70% ethanol. Five mg total RNA was
reverse-transcribed using Reverse Transcriptase Superscript III
(Invitrogen) according to the manufacturer’s protocol. Quantita-
tive real-time RT-PCR was performed using SYBR Green kit
according to the manufacturer’s instructions (ABI Prism 7000,
Applied Biosystems) and primer pairs listed in Table S8. Relative
expression levels were normalized to b-actin levels.
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